Genscript BiotechGNNSF 66 Days Inventory is 34.36 as of Dec. 2025, which is 35% below its 10-year median of 52.68. GuruFocus rates GNNSF with a GF Score™ of 66/100 and a GF Value™ of $2.50 (Significantly Undervalued). The stock has 4 warning signs investors should review. Among 635 Biotechnology companies, Genscript Biotech ranks better than 91.02% on this metric.
The historical rank and industry rank for Genscript Biotech's Days Inventory or its related term are showing as below:
GNNSF'
s Days Inventory Range Over the Past 10 Years
Min: 29.67 Med: 52.68 Max: 71.21
Current: 32.74
During the past 12 years, Genscript Biotech's highest Days Inventory was 71.21. The lowest was 29.67. And the median was 52.68.
GNNSF's Days Inventory is ranked better than 91.02% of 635
companies
in the Biotechnology industry
Industry Median: 183.23
vs GNNSF: 32.74
Genscript Biotech's Days Inventory
declined
from Dec. 2024 (43.81) to Dec. 2025 (34.36).
Inventory Turnover measures how fast the company turns over its inventory within a year.
Genscript Biotech's Inventory Turnover for the
six
months ended in Dec. 2025 was 5.31.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Genscript Biotech's Inventory-to-Revenue for the
six
months ended in Dec. 2025 was 0.09.
Genscript Biotech (OTCPK:GNNSF) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Genscript Biotech's Inventory Turnover for the
six
months ended in Dec. 2025 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Genscript Biotech's Inventory to Revenue for the
six
months ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Genscript Biotech Days Inventory Related Terms
Genscript Biotech Days Inventory Historical Data
* Premium members only.
The historical data trend for Genscript Biotech's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
GNNSF vs VRTX, REGN, ALNY: Days Inventory Comparison
For the Biotechnology subindustry, Genscript Biotech's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Genscript Biotech Days Inventory vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Genscript Biotech's Days Inventory distribution charts can be found below:
* The bar in red indicates where Genscript Biotech's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Genscript Biotech (GNNSF) has a Days Inventory of 34.36 as of Dec. 2025. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Genscript Biotech and its competitors. This is 35% below median its historical median of 52.68. Over the past decade, Genscript Biotech's Days Inventory has ranged from 29.67 to 71.21. According to the industry distribution chart, Genscript Biotech ranks #57 out of 635 companies in the Biotechnology industry, placing it in the top 9%.
Is Genscript Biotech's Days Inventory too high?
Genscript Biotech's current Days Inventory of 34.36 is 35% below median its 10-year median of 52.68. Over the past 10 years, this metric has ranged from a low of 29.67 to a high of 71.21. The Biotechnology industry median Days Inventory is 183.23. Genscript Biotech's value of 34.36 is 81.2% below this industry median. Based on the distribution chart, Genscript Biotech ranks #57 out of 635 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Genscript Biotech has a GF Score™ of 66/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Genscript Biotech's Days Inventory compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Genscript Biotech ranks #57 out of 635 companies for Days Inventory. This places Genscript Biotech in the top 9% of its industry — outperforming the majority of peers. The industry median Days Inventory is 183.23. Genscript Biotech's value of 34.36 is 81.2% below this benchmark. Historically, Genscript Biotech's own Days Inventory has ranged from 29.67 to 71.21 over the past decade. While the company's 10-year median is 52.68 vs. the industry median of 183.23, Genscript Biotech has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Biotechnology company?
The median Days Inventory among Biotechnology companies is 183.23, based on 635 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Genscript Biotech's current Days Inventory of 34.36 is 81.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Genscript Biotech and its competitors. For the Biotechnology industry, the median Days Inventory is 183.23 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Genscript Biotech's current Days Inventory is 34.36, which is 35% below median its own 10-year median of 52.68. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Genscript Biotech stock overvalued right now?
Based on GuruFocus' analysis, Genscript Biotech (GNNSF) is currently considered Significantly Undervalued. The stock's GF Value™ is $2.50, compared to a current price of $1.60 — trading 36% below its estimated fair value. The current Days Inventory is 34.36, which is 35% below median its 10-year median of 52.68 and 81.2% below the Biotechnology industry median of 183.23. Genscript Biotech's overall GF Score™ is 66/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Genscript Biotech (GNNSF), the current Days Inventory is 34.36 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Genscript Biotech (GNNSF) Overvalued in 2026?
Based on GuruFocus' analysis, Genscript Biotech stock appears to be undervalued.
The current stock price of $1.60 is trading 36% below its estimated GF Value™ of $2.50.
GuruFocus considers Genscript Biotech to be Significantly Undervalued.
Key valuation signals for GNNSF:
Days Inventory: 34.36 (35% below median its 10-year median of 52.68)
GF Value™: $2.50 vs. price of $1.60 (36% below fair value)
Industry Position: 81.2% below the Biotechnology median (#57 of 635)
No single metric tells the full story. See the GNNSF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
GenScript Biotech Corp is an investment holding company engaged in the manufacture and sale of life science research products and services, including life science services and products, biologics development services, and industrial synthetic biology products. Its segments include life science services and products, which generate maximum revenue and provide research services and products; biologics development services, which support the development of therapeutic antibodies and CGT products; industrial synthetic biology, which provides enzyme development and production using engineered microbial strains; and the operation unit, which provides shared services. It operates in Mainland China, which generates maximum revenue, U.S., Europe, and the Asia Pacific excluding Mainland China.
66GF Score
Get the complete analysis for GNNSF
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
GNNSF has been successfully added to your 
